MedTrace Logo

Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles

NCT05670795 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 254

Last updated 2024-02-02

No results posted yet for this study

Summary

The aim of study is to evaluate the results of two different protocols for ovulation induction during IUI cycles. All patients undergo IUI cycles are randomly divided in to two groups. the first group is recombinant follicle stimulating hormone and the second group is the combination of recombinant follicle stimulating hormone with clomiphene citrate.

Conditions

  • Infertility Unexplained

Interventions

DRUG

Recombinant Follicle Stimulating Hormone

clinical pregnancy rates

DRUG

Recombinant Follicle Stimulating Hormone and Clomiphene Citrate

clinical pregnancy rates

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05670795 on ClinicalTrials.gov